Cancienne Jourdan M, Werner Brian C, Chen Dennis Q, Hassanzadeh Hamid, Shimer Adam L
Department of Orthopaedic Surgery, University of Virginia, PO Box 800159, Charlottesville, VA 22908, USA.
Department of Orthopaedic Surgery, University of Virginia, PO Box 800159, Charlottesville, VA 22908, USA.
Spine J. 2017 Aug;17(8):1100-1105. doi: 10.1016/j.spinee.2017.03.017. Epub 2017 Mar 22.
Although multiple studies have cited that diabetes mellitus as a risk factor decreased functional outcomes, increased infectious complications, and overall increased reoperation rate following degenerative lumbar spinal surgery, few have investigated how perioperative glycemic control influences such complications.
The primary goal of the present study was to use a national database to evaluate the association of perioperative glycemic control as demonstrated by hemoglobin A1c (HbA1c) levels in patients with diabetes undergoing primary, single-level decompression without concomitant fusion with the incidence of deep postoperative infection requiring operative irrigation and debridement. Our secondary objective was to calculate a threshold level of HbA1c above which the risk of postoperative infection after lumbar decompression increases significantly in patients with diabetes.
STUDY DESIGN/SETTING: This is a retrospective case control database study, with Level III evidence.
This study comprised private-payer patients with diabetes mellitus undergoing single-level lumbar decompression with an HbA1c laboratory value recorded in the database within 3 months of surgery.
The outcome examined in this study was deep infection following primary, single-level lumbar decompression requiring surgical intervention. Postoperative infection within 1 year of the index primary, single-level lumbar decompression was assessed using Current Procedural Terminology (CPT) procedure codes and the International Classification of Diseases, 9th Revision (ICD-9) diagnostic codes.
The Humana private-payer dataset from the PearlDiver database was used for this study. The database was queried for patients with diabetes mellitus undergoing primary, single-level lumbar decompression surgery using CPT codes. Patients with a diagnosis of diabetes mellitus who had an HbA1c level drawn within 3 months before or after their surgical date were then selected to form the study group using the ICD-9 diagnostic codes. Patients were then divided into groups based on their HbA1c level by increments of 0.5 mg/dL. The incidence of deep infection requiring operative intervention within 1 year for each HbA1c group was then identified using CPT and ICD-9 codes. A receiver operating characteristic (ROC) and area under the curve (AUC) analysis was performed to determine an optimal threshold value of the HbA1c above which the risk of postoperativeinfection was significantly increased. The threshold value was tested using a multivariable binomial logistic regression analysis.
A total of 5,194 patients who underwent primary, single-level lumbar decompression with diabetes and a perioperative HbA1c recorded within 3 months of surgery were included in the study. The rate of infection ranged from a low of 0.5% up to 3.5% for patients with an HbA1c level >11.0 mg/dL (p=.012). The inflection point of the ROC curve corresponded to an HbA1c level above 7.5 mg/dL (p=.01, AUC=0.71, specificity=70%, sensitivity=53%). After controlling for patient demographics and medical comorbidities, patients with an HbA1c level of 7.5 mg/dL or above had a significantly higher risk for deep infection compared with patients below this threshold (odds ratio: 2.9, 95% confidence interval: 1.8-4.9, p<.0001).
The risk of deep postoperative infection requiring surgical intervention following single-level lumbar decompression in patients with diabetes mellitus increases as the perioperative HbA1c increases. The ROC and multivariable regression analyses determined that a perioperative HbA1c above 7.5 mg/dL could serve as a threshold for a significantly increased risk of deep postoperative infection following lumbar decompression.
尽管多项研究表明,糖尿病作为一种风险因素会降低退行性腰椎手术后的功能恢复效果,增加感染并发症,并总体提高再次手术率,但很少有研究调查围手术期血糖控制如何影响这些并发症。
本研究的主要目的是使用全国性数据库,评估糖尿病患者在接受初次单节段减压且未同时进行融合手术时,糖化血红蛋白(HbA1c)水平所反映的围手术期血糖控制与需要手术冲洗和清创的深部术后感染发生率之间的关联。我们的次要目标是计算HbA1c的阈值水平,高于此阈值,糖尿病患者腰椎减压术后感染风险会显著增加。
研究设计/设置:这是一项具有III级证据的回顾性病例对照数据库研究。
本研究纳入了在手术3个月内数据库中有HbA1c实验室值记录的、接受单节段腰椎减压的糖尿病自费患者。
本研究中观察的指标是初次单节段腰椎减压后需要手术干预的深部感染。使用当前操作术语(CPT)程序代码和国际疾病分类第九版(ICD - 9)诊断代码评估初次单节段腰椎减压术后1年内的感染情况。
本研究使用了PearlDiver数据库中的Humana自费数据集。通过CPT代码在数据库中查询接受初次单节段腰椎减压手术的糖尿病患者。然后使用ICD - 9诊断代码选择手术日期前后3个月内有HbA1c水平检测结果的糖尿病诊断患者组成研究组。然后根据HbA1c水平以0.5 mg/dL的增量将患者分组。接着使用CPT和ICD - 9代码确定每个HbA1c组在1年内需要手术干预的深部感染发生率。进行受试者操作特征(ROC)和曲线下面积(AUC)分析以确定HbA1c的最佳阈值,高于此阈值术后感染风险会显著增加。使用多变量二项逻辑回归分析对该阈值进行检验。
本研究共纳入5194例接受初次单节段腰椎减压且患有糖尿病且手术3个月内有围手术期HbA1c记录的患者。HbA1c水平>11.0 mg/dL的患者感染率低至0.5%,高至3.5%(p = 0.012)。ROC曲线的拐点对应HbA1c水平高于7.5 mg/dL(p = 0.01,AUC = 0.71,特异性 = 70%,敏感性 = 53%)。在控制患者人口统计学和合并症后,HbA1c水平为7.5 mg/dL或更高的患者与低于此阈值的患者相比,深部感染风险显著更高(比值比:2.9,95%置信区间:1.8 - 4.9,p < 0.0001)。
糖尿病患者单节段腰椎减压术后需要手术干预的深部感染风险随着围手术期HbA1c升高而增加。ROC和多变量回归分析确定,围手术期HbA1c高于7.5 mg/dL可作为腰椎减压术后深部感染风险显著增加的阈值。